+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Combivir"

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026 - Product Thumbnail Image

US HIV Infection Drug Market, Dosage, Price, Sales Insight 2021 - 2026

  • Report
  • February 2021
  • 360 Pages
  • United States
From
Combivir - API Insight, 2022 - Product Thumbnail Image

Combivir - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Combivir- Drug Insight, 2019 - Product Thumbnail Image

Combivir- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Combivir is a combination antiretroviral medication used to treat HIV/AIDS. It is a fixed-dose combination of two drugs, lamivudine and zidovudine, both of which are nucleoside reverse transcriptase inhibitors (NRTIs). Combivir is used to reduce the amount of HIV in the body, allowing the immune system to recover and preventing the progression of HIV to AIDS. It is usually prescribed in combination with other antiretroviral drugs. Combivir is a widely used antiretroviral medication, and is available in many countries around the world. It is generally well tolerated, with few side effects. However, it is not suitable for everyone, and should be used with caution in people with certain medical conditions. Companies in the Combivir market include GlaxoSmithKline, ViiV Healthcare, Mylan, and Teva Pharmaceuticals. Show Less Read more